OPC-88117 suppresses early and delayed afterdepolarizations and arrhythmias induced by cesium, 4-aminopyridine and digitalis in canine Purkinje fibers and in the canine heart in situ

Brett Graham, Robert F. Gilmour, Marshall S. Stanton, Douglas P. Zipes

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The effects of OPC-88117, a new investigational antiarrhythmic drug, on early and delayed afterdepolarizations (EAD and DAD, respectively) were assessed in vitro in canine Purkinje fibers and in vivo in the canine right ventricle. OPC-88117 had similar electrophysiologic properties to class I antiarrhythmic agents in that it decreased V̇max. OPC-88117 decreased the amplitude and prolonged the coupling interval of DAD induced by acetylstrophanthidin. Likewise, OPC-88117 suppressed EAD induced in vitro by 4-aminopyridine. In vivo, cesium-induced EAD, ventricular arrhythmia, and atrioventricular block were suppressed by OPC-88117. In summary, OPC-88117 suppressed DAD and EAD in vitro and inhibited EAD and triggered activity in the in situ canine heart.

Original languageEnglish
Pages (from-to)708-716
Number of pages9
JournalAmerican Heart Journal
Volume118
Issue number4
DOIs
StatePublished - 1989

Fingerprint

Purkinje Fibers
4-Aminopyridine
Cesium
Digitalis
Canidae
Cardiac Arrhythmias
Investigational Drugs
Atrioventricular Block
Anti-Arrhythmia Agents
Heart Ventricles
8-methyl-3-(4-methyl-1-piperazinyl)-2(1H)-quinolinone
In Vitro Techniques

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

OPC-88117 suppresses early and delayed afterdepolarizations and arrhythmias induced by cesium, 4-aminopyridine and digitalis in canine Purkinje fibers and in the canine heart in situ. / Graham, Brett; Gilmour, Robert F.; Stanton, Marshall S.; Zipes, Douglas P.

In: American Heart Journal, Vol. 118, No. 4, 1989, p. 708-716.

Research output: Contribution to journalArticle

@article{cf8bdfe7d7564f6082d229ebab9bbe3c,
title = "OPC-88117 suppresses early and delayed afterdepolarizations and arrhythmias induced by cesium, 4-aminopyridine and digitalis in canine Purkinje fibers and in the canine heart in situ",
abstract = "The effects of OPC-88117, a new investigational antiarrhythmic drug, on early and delayed afterdepolarizations (EAD and DAD, respectively) were assessed in vitro in canine Purkinje fibers and in vivo in the canine right ventricle. OPC-88117 had similar electrophysiologic properties to class I antiarrhythmic agents in that it decreased V̇max. OPC-88117 decreased the amplitude and prolonged the coupling interval of DAD induced by acetylstrophanthidin. Likewise, OPC-88117 suppressed EAD induced in vitro by 4-aminopyridine. In vivo, cesium-induced EAD, ventricular arrhythmia, and atrioventricular block were suppressed by OPC-88117. In summary, OPC-88117 suppressed DAD and EAD in vitro and inhibited EAD and triggered activity in the in situ canine heart.",
author = "Brett Graham and Gilmour, {Robert F.} and Stanton, {Marshall S.} and Zipes, {Douglas P.}",
year = "1989",
doi = "10.1016/0002-8703(89)90583-8",
language = "English",
volume = "118",
pages = "708--716",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - OPC-88117 suppresses early and delayed afterdepolarizations and arrhythmias induced by cesium, 4-aminopyridine and digitalis in canine Purkinje fibers and in the canine heart in situ

AU - Graham, Brett

AU - Gilmour, Robert F.

AU - Stanton, Marshall S.

AU - Zipes, Douglas P.

PY - 1989

Y1 - 1989

N2 - The effects of OPC-88117, a new investigational antiarrhythmic drug, on early and delayed afterdepolarizations (EAD and DAD, respectively) were assessed in vitro in canine Purkinje fibers and in vivo in the canine right ventricle. OPC-88117 had similar electrophysiologic properties to class I antiarrhythmic agents in that it decreased V̇max. OPC-88117 decreased the amplitude and prolonged the coupling interval of DAD induced by acetylstrophanthidin. Likewise, OPC-88117 suppressed EAD induced in vitro by 4-aminopyridine. In vivo, cesium-induced EAD, ventricular arrhythmia, and atrioventricular block were suppressed by OPC-88117. In summary, OPC-88117 suppressed DAD and EAD in vitro and inhibited EAD and triggered activity in the in situ canine heart.

AB - The effects of OPC-88117, a new investigational antiarrhythmic drug, on early and delayed afterdepolarizations (EAD and DAD, respectively) were assessed in vitro in canine Purkinje fibers and in vivo in the canine right ventricle. OPC-88117 had similar electrophysiologic properties to class I antiarrhythmic agents in that it decreased V̇max. OPC-88117 decreased the amplitude and prolonged the coupling interval of DAD induced by acetylstrophanthidin. Likewise, OPC-88117 suppressed EAD induced in vitro by 4-aminopyridine. In vivo, cesium-induced EAD, ventricular arrhythmia, and atrioventricular block were suppressed by OPC-88117. In summary, OPC-88117 suppressed DAD and EAD in vitro and inhibited EAD and triggered activity in the in situ canine heart.

UR - http://www.scopus.com/inward/record.url?scp=0024440481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024440481&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(89)90583-8

DO - 10.1016/0002-8703(89)90583-8

M3 - Article

C2 - 2552784

AN - SCOPUS:0024440481

VL - 118

SP - 708

EP - 716

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4

ER -